Cargando…
Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer
BACKGROUND: Insulin-like growth factor-binding protein 7 (IGFBP7) has been found to be a tumor suppressor in several human cancers, but the role of IGFBP7 in gastric cancer has not yet been fully investigated. Herein, we examined the epigenetic downregulation of IGFBP7 expression in gastric cancer....
Autores principales: | Kim, Jin, Kim, Woo Ho, Byeon, Sun-Ju, Lee, Byung Lan, Kim, Min A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980839/ https://www.ncbi.nlm.nih.gov/pubmed/29580038 http://dx.doi.org/10.22034/APJCP.2018.19.3.667 |
Ejemplares similares
-
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020) -
HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma
por: Ruan, Wenjing, et al.
Publicado: (2010) -
Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
por: Lee, D. Y., et al.
Publicado: (1997) -
IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis
por: Mohanraj, Lathika, et al.
Publicado: (2013) -
Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer()
por: Kim, Seung Tae, et al.
Publicado: (2015)